# Cerebrolysin

Canonical source: https://retacompare.com/encyclopedia/cerebrolysin

Multi-modal neurotrophic effects mimicking BDNF/CNTF signaling; protein synthesis modulation; neuroprotection in ischemia models.

Reference facts

Also known asPorcine brain peptide complexCategoryNootropic & CognitiveMechanism of actionMulti-modal neurotrophic effects mimicking BDNF/CNTF signaling; protein synthesis modulation; neuroprotection in ischemia models.TargetsMulti-target neurotrophic signalingIndications under research or approvedApproved Europe/Asia (ischemic stroke, vascular dementia, TBI); not US-approvedRegulatory status (reference entry)Not FDA-approvedHalf-lifeVariable (mixture)Sequence notesMixture of low-molecular-weight peptides and free amino acids (~85% free aa, 15% peptides <10 kDa) derived from enzymatic breakdown of porcine brain protein.Originator / sponsorEver Neuro Pharma (Austria)First reported1949
    Primary References

Bornstein et al., J Neural Transm 2018 (Cerebrolysin meta-analysis)


    Explore research articles about Cerebrolysin


    This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.

## Sources

- Bornstein et al., J Neural Transm 2018 (Cerebrolysin meta-analysis): https://pubmed.ncbi.nlm.nih.gov/29497821/